ATLASAgios Pharmaceuticals (AGIO) earnings date: Nov 5, 2026
Agios Pharmaceuticals (AGIO) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of -$1.32.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AGIO
| Last price | $30.60 (+0.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.9% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Agios Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Agios Pharmaceuticals reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Agios Pharmaceuticals. You can switch it off at any time.
Alert me before AGIO reportsFree to start. Creating an account takes under a minute.
Notify me when Agios Pharmaceuticals reports
Track AGIO free Add Agios Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
AGIO earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.32 |
| Last report | Jul 30, 2026 · In line |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +0.9% |
| Average move around a report | ±8.0% (last 4) |
| Sector | Healthcare · Biotechnology |
Agios Pharmaceuticals earnings history: last 4 reports
Agios Pharmaceuticals last reported on Jul 30, 2026: EPS of -$1.69 against an estimate of -$1.66 (-1.8% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | -$1.66 | -$1.69 | -1.8% | In line | -14.3% |
| Apr 29, 2026 | -$1.79 | -$1.69 | +5.6% | Beat | +12.9% |
| Feb 23, 2026 | $0.42 | $0.40 | -4.8% | Miss | +3.9% |
| Feb 12, 2026 | -$1.94 | -$1.85 | +4.6% | Beat | +0.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AGIO
See the fair value, the probability range and the earnings history of Agios Pharmaceuticals on its ATLAS page.
Agios Pharmaceuticals (AGIO) stock analysisPlans from €3.99 a month.
Agios Pharmaceuticals earnings: frequently asked questions
When does Agios Pharmaceuticals (AGIO) report earnings?
Agios Pharmaceuticals is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AGIO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.32 per share (USD). Estimates can change before the report.
How often does AGIO beat earnings estimates?
Of its last 4 reports with a recorded result, Agios Pharmaceuticals beat the EPS estimate 2 times; the average surprise was +0.9%. Past results do not predict the next one.
How much does AGIO move around earnings?
Over its last 4 reports the stock moved an average of 8.0% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Agios Pharmaceuticals beat earnings estimates last quarter?
Agios Pharmaceuticals last reported on Jul 30, 2026: EPS of -$1.69 against an estimate of -$1.66 (-1.8% surprise), in line with the estimate.
How much does AGIO usually move in a day?
On a normal trading day the ATLAS model puts AGIO’s one-day range at about ±4.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer